Mohammed Rafii-El-Idrissi Benhnia

Profesor Contratado Doctor
rafiim@us.es
Área de conocimiento: Bioquímica y Biología Molecular
Departamento: Bioquímica Méd.y Biol.Molecular e Inmun.
Grupo: INMUNOVIROLOGIA (CTS-590)
Instituto de Inv.: IBIS
Prog. doctorado: Prog.Doct.en Biología Molecular, Biomedicina e Investigac.Clínica (RD.2011)
Tipo Año Título Fuente
Artículo2016 Immunovirological Efficacy of Once-Daily Maraviroc Plus Ritonavir-Boosted Atazanavir After 48 Weeks in Naive HIV-Infected Patients VIRAL IMMUNOLOGY
Artículo2016 Maraviroc contributes to the restoration of the homeostasis of regulatory T-cell subsets in antiretroviral-naive HIV-infected subjects CLINICAL MICROBIOLOGY AND INFECTION
Artículo2016 Monocyte Phenotype and Polyfunctionality Are Associated With Elevated Soluble Inflammatory Markers, Cytomegalovirus Infection, and Functional and Cognitive Decline in Elderly Adults JOURNALS OF GERONTOLOGY SERIES A-BIOLOGICAL SCIENCES AND MEDICAL SCIENCES
Artículo2016 Phenotype and Polyfunctional Deregulation Involving Interleukin 6 (IL-6)- and IL-10-Producing Monocytes in HIV-Infected Patients Receiving Combination Antiretroviral Therapy Differ From Those in Healthy Older Individuals JOURNAL OF INFECTIOUS DISEASES
Artículo2015 IFNL4 ss469415590 polymorphism is associated with unfavourable clinical and immunological status in HIV-infected individuals CLINICAL MICROBIOLOGY AND INFECTION
Artículo2015 Maraviroc Clinical Test (MCT) as an alternative tool to decide CCR5-antagonists prescription in naive HIV-infected patients ANTIVIRAL RESEARCH
Artículo2015 Structural and Functional Characterization of Anti-A33 Antibodies Reveal a Potent Cross-Species Orthopoxviruses Neutralizer PLOS PATHOGENS
Artículo2014 Maintenance of virologic efficacy and decrease in levels of beta 2-microglobulin, soluble CD40L and soluble CD14 after switching previously treated HIV-infected patients to an NRTI-sparing dual therapy ANTIVIRAL RESEARCH
Artículo2014 Using a Combined Computational-Experimental Approach to Predict Antibody-Specific B Cell Epitopes STRUCTURE
Artículo2013 Unusual features of vaccinia virus extracellular virion form neutralization resistance revealed in human antibody responses to the smallpox vaccine JOURNAL OF VIROLOGY
Artículo2012 Structural and biochemical characterization of the vaccinia virus envelope protein D8 and its recognition by the antibody LA5 JOURNAL OF VIROLOGY
Artículo2011 B cell-specific expression of B7-2 is required for follicular TH cell function in response to vaccinia virus JOURNAL OF IMMUNOLOGY
Artículo2010 Combination therapy of vaccinia virus infection with human anti-H3 and anti-B5 monoclonal antibodies in a small animal model ANTIVIRAL THERAPY
Revisión2009 Heavily isotype-dependent protective activities of human antibodies against vaccinia virus extracellular virion antigen B5 JOURNAL OF VIROLOGY
Revisión2009 Vaccinia virus extracellular enveloped virion neutralization in vitro and protection in vivo depend on complement JOURNAL OF VIROLOGY
Artículo2008 Redundancy and plasticity of neutralizing antibody responses are cornerstone attributes of the human immune response to the smallpox vaccine JOURNAL OF VIROLOGY
Artículo2008 Selective CD4(+) T cell help for antibody responses to a large viral pathogen: Deterministic linkage of specificities IMMUNITY
Artículo2006 Natural killer T cells recognize diacylglycerol antigens from pathogenic bacteria NATURE IMMUNOLOGY
Ponencia2006 NKT cells recognize bacterial diacylglycerols JOURNAL OF IMMUNOLOGY
Artículo2005 Signaling through CD14 attenuates the inflammatory response to Borrelia burgdorferi, the agent of Lyme disease JOURNAL OF IMMUNOLOGY
Artículo1999 Characterization of membrane melatonin receptor in mouse peritoneal macrophages: Inhibition of adenylyl cyclase by a pertussis toxin-sensitive G protein JOURNAL OF NEUROIMMUNOLOGY
Artículo1998 Specific binding of melatonin by purified cell nuclei from spleen and thymus of the rat JOURNAL OF NEUROIMMUNOLOGY
Artículo1997 Differential adrenergic regulation of rat pineal cyclic AMP production and N-acetyltransferase activity during postnatal development: involvement of G(alpha S) and G(alpha i1-2) proteins JOURNAL OF ENDOCRINOLOGY
Revisión1997 Mechanisms of action of melatonin on the human immune system: Membrane versus nuclear receptors THERAPEUTIC POTENTIAL OF MELATONIN
Artículo1997 Melatonin Enhances IL-2, IL-6, and IFN-γ Production by Human Circulating CD4+ Cells: A Possible Nuclear Receptor-Mediated Mechanism Involving T Helper Type 1 Lymphocytes and Monocytes JOURNAL OF IMMUNOLOGY
Artículo1996 Binding of [I-125]iodocyanopindolol by rat harderian gland crude membranes: Kinetic characteristics and day-night variations BIOSCIENCE REPORTS
Artículo1996 Characterization of binding sites for beta-adrenergic agonists and vasoactive intestinal peptide in the rat harderian gland MICROSCOPY RESEARCH AND TECHNIQUE
Artículo1996 Specific binding of 2-[125I]iodomelatonin by rat spleen crude membranes: Day-night variations and effect of pinealectomy and continuous light exposure JOURNAL OF PINEAL RESEARCH
Artículo1996 Specific binding of 2-[I-125]iodomelatonin by rat spleen crude membranes: Day-night variations and effect of pinealectomy and continuous light exposure JOURNAL OF PINEAL RESEARCH
Artículo1995 Immunomodulatory role of melatonin - specific binding-sites in human and rodent lymphoid-cells JOURNAL OF PINEAL RESEARCH
Artículo1995 SPECIFIC BINDING OF 2-[I-125]IODOMELATONIN BY RAT SPLENOCYTES - CHARACTERIZATION AND ITS ROLE ON REGULATION OF CYCLIC-AMP PRODUCTION JOURNAL OF NEUROIMMUNOLOGY
Este investigador no ha dirigido/tutorizado tesis

Proyectos de Investigación

Fecha de inicio Fecha de fin Rol Denominación Agencia financiadora
01/01/2014 31/12/2017 Responsable Predicción de la respuesta de anticuerpos altamente neutralizante y control del VIH en la colaboración de células TCD4+ (TFH) y ausencia de disfunciones de linfocitos B (PI13/01836) Ministerio de Economía y Competitividad (Instituto de Carlos III) (Nacional)

Contratos

Fecha de inicio Fecha de fin Rol Denominación Agencia financiadora
30/05/2016 31/07/2017 Investigador/a Role of a combined antiretroviral treatment including maraviroc in the response to hepatitis B and A virus vaccine. (2808/0831) ViiV Healthcare (Nacional)